YCM
ZVSAW

Yakira Capital Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Yakira Capital Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-414,862
Closed -$50K – 455
2022
Q3 		$50K Buy
+414,862
New +$53.6K 0.01% 277

Yakira Capital Management's ZVSAW Position: Q4 2022 in Review

Yakira Capital Management sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 414,862 shares — an estimated $50K sold.

Yakira Capital Management first reported a position in ZVSAW in Q3 2022 and held it in 1 quarter. The position peaked at $50K in Q3 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Yakira Capital Management reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Yakira Capital Management sold 414,862 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $50K.
  • Yakira Capital Management first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q3 2022 and held it in 1 quarter.
  • Yakira Capital Management's ZyVersa Therapeutics, Inc. Warrants position peaked at $50K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Yakira Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.